"Am I correct that you stated previously, or maybe someone  else,that the rate of mace in this population  would be between 11 and 12 percent on standard treatment?"

You are kind of correct. In EXAMINE trial, which influenced BETonMACE design, the event rate was ~11-12% at 18 months. BETonMACE is showing 8% event rate (0.08 per patient year). In my opinion, to best compare these two figures is to express the BETonMACE figure as events per 1.5 years (18 months), which would be 0.12 or 12%.

BDAZ